Feasibility Study of Blood Glucose Monitoring With the Non-invasive Medical Device D-Base
Feasibility of Predicting Blood Glucose Values by Measuring in the Interstitial Fluid of the Skin on the Wrist With the Non-invasive Medical Device D-Base
Sponsor: Diamontech AG
Terminated
Goals as defined in the study protocol were not met after the first study period. Study with improved device will follow.
Other Diabetes Mellitus, Type 1 trials with similar outcome
A observational or N/A phase clinical study on Diabetes Mellitus, Type 1 and Diabetes Mellitus, Type 2, this trial is terminated or withdrawn. The trial is conducted by Diamontech AG and has accumulated 6 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Jun 2023 — Jul 2024 [monthly]
Terminated
Status: Active Not Recruiting → Terminated
-
Mar 2023 — Jun 2023 [monthly]
Active Not Recruiting
-
Feb 2022 — Mar 2023 [monthly]
Active Not Recruiting
Status: Not Yet Recruiting → Active Not Recruiting
▶ Show 1 earlier version
-
Jan 2022 — Feb 2022 [monthly]
Not Yet Recruiting
First recorded
Dec 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Diamontech AG
- Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm
For direct contact, visit the study record on ClinicalTrials.gov .